Where are the prostate cancer genes? A summary of eight genome wide searches

被引:79
作者
Easton, DF
Schaid, DJ
Whittemore, AS
Isaacs, WJ
机构
[1] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Canc Res UK,Genet Epidemiol Unit, Cambridge CB1 8RN, England
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[4] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
关键词
genetic linkage analysis; ICPCG; prostate cancer susceptibility; parametric linkage; non-parametric linkage;
D O I
10.1002/pros.10300
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. There is strong evidence for genetic susceptibility to prostate cancer, but most of the genes underlying this susceptibility remain to be identified. METHODS. We reviewed the results of eight genome-wide linkage searches based on 1,293 families with multiple cases of prostate cancer. RESULTS. Across these studies, 11 linkage peaks with LOD scores in excess of 2 were identified. However, no chromosomal region was reported as significant at this level by more than one study and only one corresponded to a peak previously suggested by another group. CONCLUSIONS. These results indicate that prostate cancer is genetically complex, and that combined analyses of large family sets will be required to evaluate reliably the linkage evidence.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 54 条
[31]   MODEL MISSPECIFICATION AND MULTIPOINT LINKAGE ANALYSIS [J].
RISCH, N ;
GIUFFRA, L .
HUMAN HEREDITY, 1992, 42 (01) :77-92
[32]  
Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733
[33]  
Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO
[34]  
2-6
[35]   Evidence for autosomal dominant inheritance of prostate cancer [J].
Schaid, DJ ;
McDonnell, SK ;
Blute, ML ;
Thibodeau, SN .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1425-1438
[36]   Genome-wide scan for linkage in Finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26 [J].
Schleutker, J ;
Baffoe-Bonnie, AB ;
Gillanders, E ;
Kainu, T ;
Jones, MP ;
Freas-Lutz, D ;
Markey, C ;
Gildea, D ;
Riedesel, E ;
Albertus, J ;
Gibbs, KD ;
Matikainen, M ;
Koivisto, PA ;
Tammela, T ;
Bailey-Wilson, JE ;
Trent, JM ;
Kallioniemi, OP .
PROSTATE, 2003, 57 (04) :280-289
[37]  
Schleutker J, 2000, CLIN CANCER RES, V6, P4810
[38]   ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer [J].
Severi, G ;
Giles, GG ;
Southey, MC ;
Tesoriero, A ;
Tilley, W ;
Neufing, P ;
Morris, H ;
English, DR ;
McCredie, MRE ;
Boyle, P ;
Hopper, JL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (11) :818-824
[39]   Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q [J].
Slager, SL ;
Schaid, DJ ;
Cunningham, JM ;
McDonnell, SK ;
Marks, AF ;
Peterson, BJ ;
Hebbring, SJ ;
Anderson, S ;
French, AJ ;
Thibodeau, SN .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :759-762
[40]   Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search [J].
Smith, JR ;
Freije, D ;
Carpten, JD ;
Gronberg, H ;
Xu, JF ;
Isaacs, SD ;
Brownstein, MJ ;
Bova, GS ;
Guo, H ;
Bujnovszky, P ;
Nusskern, DR ;
Damber, JE ;
Bergh, A ;
Emanuelsson, M ;
Kallioniemi, OP ;
WalkerDaniels, J ;
BaileyWilson, JE ;
Beaty, TH ;
Meyers, DA ;
Walsh, PC ;
Collins, FS ;
Trent, JM ;
Isaacs, WB .
SCIENCE, 1996, 274 (5291) :1371-1374